Global Oncolytic Virus Market Research Report 2023(Status and Outlook)

Global Oncolytic Virus Market Research Report 2023(Status and Outlook)



Report Overview

An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.

To date, two genetically engineered oncolytic viruses have been approved for marketing as drugs. One is Oncorine (H101, the same construct as ONYX‐015),9 an E1B‐deleted adenovirus, which was approved in China for head and neck cancer and esophagus cancer in 2005. The use and clinical data of Oncorine is so far limited to China. The other is T‐Vec (talimogene laherparepvec, IMLYGIC, formerly OncoVEXGM‐CSF), which was approved for melanoma by the FDA in the USA in October 2015 and was subsequently approved in Europe in January 2016 and in Australia in May 2016. For developing product, there are 3 products in Phase 3, 8 products in Phase 2, 7 products in Phase 1 and 3 products in Preclinical. Market competition is intense. Amgen, Shanghai Sunway Biotech, Oncolytics Biotech, Viralytics, Transgene SA are the leading developers in the industry; with high investment in research marketing and they will monopoly position in the industry. Other players include Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics and Cold Genesys, etc.

The Global Oncolytic Virus Market Size was estimated at USD 16 million in 2022 and is projected to reach USD 25.36 million by 2029, exhibiting a CAGR of 6.80% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Oncolytic Virus market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oncolytic Virus Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oncolytic Virus market in any manner.

Global Oncolytic Virus Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Amgen

Shanghai Sunway Biotech

Market Segmentation (by Type)

Imlygic

Oncorine

Others

Market Segmentation (by Application)

Park

Residential

Factory

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Oncolytic Virus Market

Overview of the regional outlook of the Oncolytic Virus Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Oncolytic Virus
1.2 Key Market Segments
1.2.1 Oncolytic Virus Segment by Type
1.2.2 Oncolytic Virus Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Oncolytic Virus Market Overview
2.1 Global Market Overview
2.1.1 Global Oncolytic Virus Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Oncolytic Virus Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Oncolytic Virus Market Competitive Landscape
3.1 Global Oncolytic Virus Sales by Manufacturers (2018-2023)
3.2 Global Oncolytic Virus Revenue Market Share by Manufacturers (2018-2023)
3.3 Oncolytic Virus Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Oncolytic Virus Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Oncolytic Virus Sales Sites, Area Served, Product Type
3.6 Oncolytic Virus Market Competitive Situation and Trends
3.6.1 Oncolytic Virus Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oncolytic Virus Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Oncolytic Virus Industry Chain Analysis
4.1 Oncolytic Virus Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Oncolytic Virus Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Oncolytic Virus Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncolytic Virus Sales Market Share by Type (2018-2023)
6.3 Global Oncolytic Virus Market Size Market Share by Type (2018-2023)
6.4 Global Oncolytic Virus Price by Type (2018-2023)
7 Oncolytic Virus Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncolytic Virus Market Sales by Application (2018-2023)
7.3 Global Oncolytic Virus Market Size (M USD) by Application (2018-2023)
7.4 Global Oncolytic Virus Sales Growth Rate by Application (2018-2023)
8 Oncolytic Virus Market Segmentation by Region
8.1 Global Oncolytic Virus Sales by Region
8.1.1 Global Oncolytic Virus Sales by Region
8.1.2 Global Oncolytic Virus Sales Market Share by Region
8.2 North America
8.2.1 North America Oncolytic Virus Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oncolytic Virus Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oncolytic Virus Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oncolytic Virus Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oncolytic Virus Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Amgen
9.1.1 Amgen Oncolytic Virus Basic Information
9.1.2 Amgen Oncolytic Virus Product Overview
9.1.3 Amgen Oncolytic Virus Product Market Performance
9.1.4 Amgen Business Overview
9.1.5 Amgen Oncolytic Virus SWOT Analysis
9.1.6 Amgen Recent Developments
9.2 Shanghai Sunway Biotech
9.2.1 Shanghai Sunway Biotech Oncolytic Virus Basic Information
9.2.2 Shanghai Sunway Biotech Oncolytic Virus Product Overview
9.2.3 Shanghai Sunway Biotech Oncolytic Virus Product Market Performance
9.2.4 Shanghai Sunway Biotech Business Overview
9.2.5 Shanghai Sunway Biotech Oncolytic Virus SWOT Analysis
9.2.6 Shanghai Sunway Biotech Recent Developments
10 Oncolytic Virus Market Forecast by Region
10.1 Global Oncolytic Virus Market Size Forecast
10.2 Global Oncolytic Virus Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Oncolytic Virus Market Size Forecast by Country
10.2.3 Asia Pacific Oncolytic Virus Market Size Forecast by Region
10.2.4 South America Oncolytic Virus Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Oncolytic Virus by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Oncolytic Virus Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Oncolytic Virus by Type (2024-2029)
11.1.2 Global Oncolytic Virus Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Oncolytic Virus by Type (2024-2029)
11.2 Global Oncolytic Virus Market Forecast by Application (2024-2029)
11.2.1 Global Oncolytic Virus Sales (K MT) Forecast by Application
11.2.2 Global Oncolytic Virus Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings